Medicines as a service :: a new commercial model for big pharma in the postblockbuster world /
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Körperschaft: | |
| Weitere Verfasser: | , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Santa Monica, CA :
RAND Health,
[2012]
|
| Schriftenreihe: | Occasional paper (Rand Corporation)
|
| Schlagworte: | |
| Online-Zugang: | DE-862 DE-863 |
| Zusammenfassung: | The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value. |
| Beschreibung: | Title from PDF caption. |
| Beschreibung: | 1 online resource (1 PDF file (11 pages)) |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 9780833076465 0833076469 9780833076458 0833076450 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn893183697 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 140829s2012 cau ob 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c NLM |d EBLCP |d MHW |d E7B |d STF |d KLG |d S4S |d JSTOR |d OCLCF |d DEBSZ |d YDXCP |d AU@ |d NKT |d CUS |d ZCU |d MERUC |d OCLCQ |d COCUF |d LND |d OCLCO |d VFL |d OCLCA |d U3W |d OCLCA |d LOA |d ICG |d WRM |d OCLCQ |d NRAMU |d OCLCA |d VT2 |d EZ9 |d OCLCQ |d TKN |d DKC |d OCLCQ |d OCLCO |d OCL |d PIFAG |d N$T |d AGLDB |d COO |d D6H |d VNS |d VTS |d AJS |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ | ||
| 016 | 7 | |a 101640300 |2 DNLM | |
| 019 | |a 804665552 |a 818105683 |a 842699759 |a 903663785 |a 907209128 | ||
| 020 | |a 9780833076465 | ||
| 020 | |a 0833076469 | ||
| 020 | |a 9780833076458 |q (electronic bk.) | ||
| 020 | |a 0833076450 |q (electronic bk.) | ||
| 035 | |a (OCoLC)893183697 |z (OCoLC)804665552 |z (OCoLC)818105683 |z (OCoLC)842699759 |z (OCoLC)903663785 |z (OCoLC)907209128 | ||
| 037 | |b 00022221 | ||
| 037 | |a 22573/ctt99zkn |b JSTOR | ||
| 042 | |a nlmcopyc | ||
| 050 | 4 | |a HV5840 |b .M38 2012 | |
| 060 | 0 | 0 | |a WT 500 |
| 072 | 7 | |a MED071000 |2 bisacsh | |
| 082 | 7 | |a 362.29/90941 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Mattke, Soeren. |0 http://id.loc.gov/authorities/names/no2009072894 | |
| 245 | 1 | 0 | |a Medicines as a service : |b a new commercial model for big pharma in the postblockbuster world / |c Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |
| 260 | |a Santa Monica, CA : |b RAND Health, |c [2012] | ||
| 300 | |a 1 online resource (1 PDF file (11 pages)) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Occasional paper | |
| 500 | |a Title from PDF caption. | ||
| 504 | |a Includes bibliographical references. | ||
| 520 | 3 | |a The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value. | |
| 588 | 0 | |a Version viewed Sept. 9, 2014. | |
| 505 | 0 | |a Medicines as a Service. | |
| 650 | 0 | |a Pharmaceutical services. |0 http://id.loc.gov/authorities/subjects/sh85100589 | |
| 650 | 0 | |a Pharmaceutical industry. | |
| 650 | 0 | |a Mathematical models. |0 http://id.loc.gov/authorities/subjects/sh85082124 | |
| 650 | 1 | 2 | |a Chronic Disease |x drug therapy |
| 650 | 2 | 2 | |a Drug Industry |x economics |
| 650 | 2 | 2 | |a Medication Adherence |
| 650 | 2 | 2 | |a Developing Countries |
| 650 | 2 | 2 | |a Models, Theoretical |
| 650 | 2 | |a Pharmaceutical Services |0 https://id.nlm.nih.gov/mesh/D010593 | |
| 650 | 2 | |a Drug Industry |0 https://id.nlm.nih.gov/mesh/D004345 | |
| 650 | 6 | |a Services pharmaceutiques. | |
| 650 | 6 | |a Industrie pharmaceutique. | |
| 650 | 6 | |a Modèles mathématiques. | |
| 650 | 7 | |a mathematical models. |2 aat | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Mathematical models |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |2 fast | |
| 650 | 7 | |a Pharmaceutical services |2 fast | |
| 700 | 1 | |a Klautzer, Lisa. |0 http://id.loc.gov/authorities/names/no2011184674 | |
| 700 | 1 | |a Mengistu, Tewodaj. |0 http://id.loc.gov/authorities/names/no2014073872 | |
| 710 | 2 | |a RAND Health. |0 http://id.loc.gov/authorities/names/n2001145525 | |
| 776 | 0 | 8 | |i Print version: |a Mattke, Soeren. |t Medicines as a Service : A New Commercial Model for Big Pharma in the Postblockbuster World. |d Santa Monica : RAND Corporation, ©2012 |
| 830 | 0 | |a Occasional paper (Rand Corporation) |0 http://id.loc.gov/authorities/names/no2004031492 | |
| 966 | 4 | 0 | |l DE-862 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=471726 |3 Volltext |
| 966 | 4 | 0 | |l DE-863 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=471726 |3 Volltext |
| 938 | |a EBL - Ebook Library |b EBLB |n EBL981579 | ||
| 938 | |a ebrary |b EBRY |n ebr10583965 | ||
| 938 | |a YBP Library Services |b YANK |n 9454829 | ||
| 938 | |a EBSCOhost |b EBSC |n 471726 | ||
| 938 | |a YBP Library Services |b YANK |n 10887288 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-862 | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn893183697 |
|---|---|
| _version_ | 1826942062143995904 |
| adam_text | |
| any_adam_object | |
| author | Mattke, Soeren |
| author2 | Klautzer, Lisa Mengistu, Tewodaj |
| author2_role | |
| author2_variant | l k lk t m tm |
| author_GND | http://id.loc.gov/authorities/names/no2009072894 http://id.loc.gov/authorities/names/no2011184674 http://id.loc.gov/authorities/names/no2014073872 |
| author_corporate | RAND Health |
| author_corporate_role | |
| author_facet | Mattke, Soeren Klautzer, Lisa Mengistu, Tewodaj RAND Health |
| author_role | |
| author_sort | Mattke, Soeren |
| author_variant | s m sm |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | H - Social Science |
| callnumber-label | HV5840 |
| callnumber-raw | HV5840 .M38 2012 |
| callnumber-search | HV5840 .M38 2012 |
| callnumber-sort | HV 45840 M38 42012 |
| callnumber-subject | HV - Social Pathology, Criminology |
| collection | ZDB-4-EBA |
| contents | Medicines as a Service. |
| ctrlnum | (OCoLC)893183697 |
| dewey-full | 362.29/90941 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.29/90941 |
| dewey-search | 362.29/90941 |
| dewey-sort | 3362.29 590941 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04462cam a2200805 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn893183697</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">140829s2012 cau ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">EBLCP</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">NLM</subfield><subfield code="d">EBLCP</subfield><subfield code="d">MHW</subfield><subfield code="d">E7B</subfield><subfield code="d">STF</subfield><subfield code="d">KLG</subfield><subfield code="d">S4S</subfield><subfield code="d">JSTOR</subfield><subfield code="d">OCLCF</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">AU@</subfield><subfield code="d">NKT</subfield><subfield code="d">CUS</subfield><subfield code="d">ZCU</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">COCUF</subfield><subfield code="d">LND</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VFL</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCA</subfield><subfield code="d">LOA</subfield><subfield code="d">ICG</subfield><subfield code="d">WRM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NRAMU</subfield><subfield code="d">OCLCA</subfield><subfield code="d">VT2</subfield><subfield code="d">EZ9</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TKN</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">PIFAG</subfield><subfield code="d">N$T</subfield><subfield code="d">AGLDB</subfield><subfield code="d">COO</subfield><subfield code="d">D6H</subfield><subfield code="d">VNS</subfield><subfield code="d">VTS</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101640300</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">804665552</subfield><subfield code="a">818105683</subfield><subfield code="a">842699759</subfield><subfield code="a">903663785</subfield><subfield code="a">907209128</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780833076465</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0833076469</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780833076458</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0833076450</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)893183697</subfield><subfield code="z">(OCoLC)804665552</subfield><subfield code="z">(OCoLC)818105683</subfield><subfield code="z">(OCoLC)842699759</subfield><subfield code="z">(OCoLC)903663785</subfield><subfield code="z">(OCoLC)907209128</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="b">00022221</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">22573/ctt99zkn</subfield><subfield code="b">JSTOR</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">nlmcopyc</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HV5840</subfield><subfield code="b">.M38 2012</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">WT 500</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">362.29/90941</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mattke, Soeren.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2009072894</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Medicines as a service :</subfield><subfield code="b">a new commercial model for big pharma in the postblockbuster world /</subfield><subfield code="c">Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Santa Monica, CA :</subfield><subfield code="b">RAND Health,</subfield><subfield code="c">[2012]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (1 PDF file (11 pages))</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Occasional paper</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from PDF caption.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Version viewed Sept. 9, 2014.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Medicines as a Service.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical services.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85100589</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Mathematical models.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85082124</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Chronic Disease</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Drug Industry</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Medication Adherence</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Developing Countries</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Models, Theoretical</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Pharmaceutical Services</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D010593</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Industry</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004345</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Services pharmaceutiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Industrie pharmaceutique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Modèles mathématiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">mathematical models.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Mathematical models</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical services</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klautzer, Lisa.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2011184674</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mengistu, Tewodaj.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2014073872</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">RAND Health.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2001145525</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Mattke, Soeren.</subfield><subfield code="t">Medicines as a Service : A New Commercial Model for Big Pharma in the Postblockbuster World.</subfield><subfield code="d">Santa Monica : RAND Corporation, ©2012</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Occasional paper (Rand Corporation)</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2004031492</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-862</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=471726</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-863</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=471726</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL981579</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10583965</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">9454829</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">471726</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">10887288</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-862</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn893183697 |
| illustrated | Not Illustrated |
| indexdate | 2025-03-18T14:22:02Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n2001145525 |
| isbn | 9780833076465 0833076469 9780833076458 0833076450 |
| language | English |
| oclc_num | 893183697 |
| open_access_boolean | |
| owner | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| physical | 1 online resource (1 PDF file (11 pages)) |
| psigel | ZDB-4-EBA FWS_PDA_EBA ZDB-4-EBA |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | RAND Health, |
| record_format | marc |
| series | Occasional paper (Rand Corporation) |
| series2 | Occasional paper |
| spelling | Mattke, Soeren. http://id.loc.gov/authorities/names/no2009072894 Medicines as a service : a new commercial model for big pharma in the postblockbuster world / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. Santa Monica, CA : RAND Health, [2012] 1 online resource (1 PDF file (11 pages)) text txt rdacontent computer c rdamedia online resource cr rdacarrier Occasional paper Title from PDF caption. Includes bibliographical references. The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value. Version viewed Sept. 9, 2014. Medicines as a Service. Pharmaceutical services. http://id.loc.gov/authorities/subjects/sh85100589 Pharmaceutical industry. Mathematical models. http://id.loc.gov/authorities/subjects/sh85082124 Chronic Disease drug therapy Drug Industry economics Medication Adherence Developing Countries Models, Theoretical Pharmaceutical Services https://id.nlm.nih.gov/mesh/D010593 Drug Industry https://id.nlm.nih.gov/mesh/D004345 Services pharmaceutiques. Industrie pharmaceutique. Modèles mathématiques. mathematical models. aat MEDICAL Pharmacology. bisacsh Mathematical models fast Pharmaceutical industry fast Pharmaceutical services fast Klautzer, Lisa. http://id.loc.gov/authorities/names/no2011184674 Mengistu, Tewodaj. http://id.loc.gov/authorities/names/no2014073872 RAND Health. http://id.loc.gov/authorities/names/n2001145525 Print version: Mattke, Soeren. Medicines as a Service : A New Commercial Model for Big Pharma in the Postblockbuster World. Santa Monica : RAND Corporation, ©2012 Occasional paper (Rand Corporation) http://id.loc.gov/authorities/names/no2004031492 |
| spellingShingle | Mattke, Soeren Medicines as a service : a new commercial model for big pharma in the postblockbuster world / Occasional paper (Rand Corporation) Medicines as a Service. Pharmaceutical services. http://id.loc.gov/authorities/subjects/sh85100589 Pharmaceutical industry. Mathematical models. http://id.loc.gov/authorities/subjects/sh85082124 Chronic Disease drug therapy Drug Industry economics Medication Adherence Developing Countries Models, Theoretical Pharmaceutical Services https://id.nlm.nih.gov/mesh/D010593 Drug Industry https://id.nlm.nih.gov/mesh/D004345 Services pharmaceutiques. Industrie pharmaceutique. Modèles mathématiques. mathematical models. aat MEDICAL Pharmacology. bisacsh Mathematical models fast Pharmaceutical industry fast Pharmaceutical services fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85100589 http://id.loc.gov/authorities/subjects/sh85082124 https://id.nlm.nih.gov/mesh/D010593 https://id.nlm.nih.gov/mesh/D004345 |
| title | Medicines as a service : a new commercial model for big pharma in the postblockbuster world / |
| title_auth | Medicines as a service : a new commercial model for big pharma in the postblockbuster world / |
| title_exact_search | Medicines as a service : a new commercial model for big pharma in the postblockbuster world / |
| title_full | Medicines as a service : a new commercial model for big pharma in the postblockbuster world / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |
| title_fullStr | Medicines as a service : a new commercial model for big pharma in the postblockbuster world / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |
| title_full_unstemmed | Medicines as a service : a new commercial model for big pharma in the postblockbuster world / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |
| title_short | Medicines as a service : |
| title_sort | medicines as a service a new commercial model for big pharma in the postblockbuster world |
| title_sub | a new commercial model for big pharma in the postblockbuster world / |
| topic | Pharmaceutical services. http://id.loc.gov/authorities/subjects/sh85100589 Pharmaceutical industry. Mathematical models. http://id.loc.gov/authorities/subjects/sh85082124 Chronic Disease drug therapy Drug Industry economics Medication Adherence Developing Countries Models, Theoretical Pharmaceutical Services https://id.nlm.nih.gov/mesh/D010593 Drug Industry https://id.nlm.nih.gov/mesh/D004345 Services pharmaceutiques. Industrie pharmaceutique. Modèles mathématiques. mathematical models. aat MEDICAL Pharmacology. bisacsh Mathematical models fast Pharmaceutical industry fast Pharmaceutical services fast |
| topic_facet | Pharmaceutical services. Pharmaceutical industry. Mathematical models. Chronic Disease drug therapy Drug Industry economics Medication Adherence Developing Countries Models, Theoretical Pharmaceutical Services Drug Industry Services pharmaceutiques. Industrie pharmaceutique. Modèles mathématiques. mathematical models. MEDICAL Pharmacology. Mathematical models Pharmaceutical industry Pharmaceutical services |
| work_keys_str_mv | AT mattkesoeren medicinesasaserviceanewcommercialmodelforbigpharmainthepostblockbusterworld AT klautzerlisa medicinesasaserviceanewcommercialmodelforbigpharmainthepostblockbusterworld AT mengistutewodaj medicinesasaserviceanewcommercialmodelforbigpharmainthepostblockbusterworld AT randhealth medicinesasaserviceanewcommercialmodelforbigpharmainthepostblockbusterworld |